Clincosm LogoSign in Get a demo

Refractory Acute Myeloid Leukemia

Showing 51 - 75 of 87
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Duarte (Decitabine, Pembrolizumab,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Mar 9, 2022

Refractory Acute Myeloid Leukemia, Relapsed Acute Myelomonocytic Leukemia, MDS Trial in Cleveland (CPX-351)

Recruiting
  • Refractory Acute Myeloid Leukemia
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Mar 15, 2022

Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, MDS Trial (biological, drug, procedure)

Withdrawn
  • Relapsed Acute Myeloid Leukemia
  • +2 more
  • Cytokine-induced memory-like NK cells
  • +4 more
  • (no location specified)
Feb 23, 2022

Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte

Active, not recruiting
  • Adult Acute Myeloid Leukemia in Remission
  • +12 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Allogeneic Stem Cell Transplant Recipient, Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Recurrent Acute Myeloid

Recruiting
  • Allogeneic Stem Cell Transplant Recipient
  • +3 more
  • Cytarabine Hydrochloride
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 7, 2022

Myelodysplastic Syndrome RAEB-I or RAEB-II, Refractory Acute Myeloid Leukemia, Refractory CML Myeloid Blast Crisis Trial in

Completed
  • Myelodysplastic Syndrome RAEB-I or RAEB-II
  • +2 more
  • GM-CSF secreting leukemia vaccine
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 28, 2022

Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

Recruiting
  • Myelodysplastic Syndrome
  • +16 more
  • Computed Tomography
  • +6 more
  • Scottsdale, Arizona
  • +2 more
Feb 3, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Anti-OX40 Agonist Monoclonal Antibody

Active, not recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Anti-OX40 Agonist Monoclonal Antibody PF-04518600
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 25, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Edicotinib, Pharmacokinetic Study)

Terminated
Has Results
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 1, 2021

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blasts 5 Percent or More of Bone Marrow Nucleated Cells,

Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +10 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 17, 2021

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia-2, High Grade Malignant Tumor Trial in

Completed
Has Results
  • Blasts 10 Percent or More of Bone Marrow Nucleated Cells
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 11, 2021

Acute Myeloid Leukemia, Relapse Leukemia, Refractory Acute Myeloid Leukemia Trial in Beijing (chimeric antigen receptor T cell)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • chimeric antigen receptor T cell
  • Beijing, Beijing, China
    Beijing Boren Hospital
Sep 14, 2021

Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL, Leukemia Cutis, Recurrent Acute Myeloid Leukemia Trial in New York

Completed
Has Results
  • Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 11, 2021

Acute Myeloid Leukemia, Hematopoietic and Lymphoid System Tumor, Myelodysplastic Syndrome Trial in United States (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2021

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Canada, United States (Enasidenib, Enasidenib

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Birmingham, Alabama
  • +17 more
Jun 21, 2021

Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (drug, biological, other)

Completed
  • Recurrent Adult Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jun 18, 2021

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

Recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +3 more
  • Gemtuzumab Ozogamicin
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • Houston, Texas
    M D Anderson Cancer Center
Jun 2, 2021

Refractory Acute Myeloid Leukemia Trial in Shanghai (Aza-Ven-allo-HSCT)

Recruiting
  • Refractory Acute Myeloid Leukemia
  • Shanghai, China
  • +2 more
May 27, 2021

Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A, Fibroblast Growth Factor Basic Form Measurement, FLT3 Internal

Recruiting
  • Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A
  • +4 more
  • Chicago, Illinois
    Northwestern University
Apr 30, 2021

Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome, Recurrent Myeloproliferative Tumor Trial in Chicago

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • +4 more
  • Chicago, Illinois
    Northwestern University
Mar 26, 2021

Blasts Under 5 Percent of Peripheral Blood White Cells, Bone Marrow Blasts Decreased by 50 Percent or More Compared to

Withdrawn
  • Blasts Under 5 Percent of Peripheral Blood White Cells
  • +4 more
  • Buffalo, New York
  • +1 more
Mar 8, 2021

Refractory Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Moscow (Preparative regimen)

Recruiting
  • Refractory Acute Myeloid Leukemia
  • Refractory Acute Lymphoblastic Leukemia
  • Preparative regimen
  • Moscow, Russian Federation
    Dmitry Rogachev National Research Center of Pediatric Hematology
Nov 19, 2020

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Alvocidib Hydrochloride, Decitabine,

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Alvocidib Hydrochloride
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 9, 2020

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

Terminated
Has Results
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 29, 2020